Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an announcement.
Lifecare ASA announced the commencement of the exercise period for over 4 million warrants related to a rights issue completed in June 2024, allowing holders to subscribe for new shares at a set price. The largest shareholder, Lacal AS, has already exercised a significant portion of these warrants. The new shares are expected to be registered and delivered by late June 2025, with implications for shareholders who do not exercise their warrants, as they may face dilution of their holdings.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes. The company is particularly focused on bringing the next generation of Continuous Glucose Monitoring (CGM) systems to market, utilizing osmotic pressure as a sensing principle. Their sensor technology is applicable for monitoring a wide range of analytes and molecules in both humans and pets.
Average Trading Volume: 40,077
Current Market Cap: NOK109.4M
For a thorough assessment of LFC0 stock, go to TipRanks’ Stock Analysis page.